PARIANO, MARILENA
 Distribuzione geografica
Continente #
NA - Nord America 3.267
AS - Asia 2.139
EU - Europa 1.858
SA - Sud America 328
Continente sconosciuto - Info sul continente non disponibili 244
AF - Africa 60
OC - Oceania 5
Totale 7.901
Nazione #
US - Stati Uniti d'America 3.084
SG - Singapore 981
IT - Italia 701
CN - Cina 305
HK - Hong Kong 277
BR - Brasile 247
IE - Irlanda 242
RU - Federazione Russa 221
VN - Vietnam 177
DE - Germania 140
FR - Francia 111
GB - Regno Unito 79
CA - Canada 76
BD - Bangladesh 74
FI - Finlandia 67
IN - India 63
KR - Corea 61
SE - Svezia 42
NL - Olanda 40
RO - Romania 39
AT - Austria 35
MX - Messico 31
TR - Turchia 31
AR - Argentina 30
JP - Giappone 27
UA - Ucraina 23
PL - Polonia 21
PK - Pakistan 18
LT - Lituania 17
BE - Belgio 16
IQ - Iraq 16
ES - Italia 15
CO - Colombia 14
CR - Costa Rica 14
IL - Israele 14
PH - Filippine 14
ZA - Sudafrica 13
ID - Indonesia 12
UZ - Uzbekistan 12
SA - Arabia Saudita 11
TT - Trinidad e Tobago 10
CH - Svizzera 9
CW - ???statistics.table.value.countryCode.CW??? 9
CZ - Repubblica Ceca 9
EC - Ecuador 9
JM - Giamaica 9
PR - Porto Rico 9
MA - Marocco 8
SC - Seychelles 8
CL - Cile 7
EG - Egitto 7
GT - Guatemala 7
MY - Malesia 7
VE - Venezuela 7
HN - Honduras 6
JO - Giordania 6
PE - Perù 6
SV - El Salvador 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
GR - Grecia 5
NI - Nicaragua 5
RS - Serbia 5
AZ - Azerbaigian 4
BO - Bolivia 4
CI - Costa d'Avorio 4
EE - Estonia 4
TH - Thailandia 4
AU - Australia 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
PT - Portogallo 3
BG - Bulgaria 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
GP - Guadalupe 1
HT - Haiti 1
HU - Ungheria 1
Totale 7.649
Città #
Singapore 742
San Jose 367
Ashburn 303
Perugia 303
Hong Kong 275
Chandler 274
Dublin 234
Santa Clara 119
Boardman 98
Council Bluffs 95
Los Angeles 87
Moscow 78
Munich 77
San Mateo 71
Beijing 70
New York 70
Ann Arbor 67
The Dalles 66
Lauterbourg 64
Seoul 58
Altamura 52
Phoenix 47
Dong Ket 46
Princeton 45
Medford 42
Lawrence 40
Hanoi 37
Ho Chi Minh City 37
Rome 35
Dallas 34
Turku 31
Wilmington 31
Andover 27
Piscataway 27
Bucharest 26
North Bergen 26
São Paulo 26
Orem 23
Tokyo 23
Vienna 23
Brooklyn 22
Des Moines 21
Montreal 21
Bologna 20
Helsinki 20
Atlanta 19
Milan 19
Stockholm 18
Dearborn 16
Vicenza 16
Brussels 15
Chicago 15
Denver 15
Warsaw 15
Amsterdam 14
Frankfurt am Main 14
Boston 12
Hefei 12
Lappeenranta 12
Nuremberg 12
Verona 12
Chennai 11
Houston 11
Johannesburg 11
Ankara 10
Belo Horizonte 10
Da Nang 10
Poplar 10
Redmond 10
San José 10
Buffalo 9
Haiphong 9
London 9
Mexico City 9
Norwalk 9
Querétaro 9
Toronto 9
Woodbridge 9
Charlotte 8
Falls Church 8
Guangzhou 8
Manchester 8
Mumbai 8
New Orleans 8
Rio de Janeiro 8
Riverbank 8
San Paolo di Civitate 8
Shanghai 8
Vilnius 8
Willemstad 8
Camerino 7
Columbus 7
Lahore 7
Palermo 7
Shenzhen 7
Turin 7
Amman 6
Baghdad 6
Barnet 6
Brasília 6
Totale 4.863
Nome #
Autophagy and LAP in the Fight against Fungal Infections: Regulation and Therapeutics 197
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis 181
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis 178
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 165
Cellular proteostasis: a new twist in the action of thymosin α1 163
Selectively targeting key inflammatory pathways in cystic fibrosis 155
Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome 148
Cardiolipin-mediated temporal response to hydroquinone toxicity in human retinal pigmented epithelial cell line 147
Microbes in the Era of Circadian Medicine 147
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 147
Thymosin α1 protects from CTLA-4 intestinal immunopathology 143
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasis 141
Defective Glyoxalase 1 Contributes to Pathogenic Inflammation in Cystic Fibrosis 141
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. 140
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy 138
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 137
Anakinra activates superoxide dismutase 2 to mitigate inflammasome activity 133
Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting 132
A shifted composition of the lung microbiota conditions the antifungal response of immunodeficient mice 130
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 128
Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1Ra 125
Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis 125
Circadian Regulation of Xenobiotic Metabolism during Anticancer Treatment 124
A Reappraisal of Thymosin Alpha1 in Cancer Therapy 122
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 121
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. 120
The circadian control of tryptophan metabolism regulates the host response to pulmonary fungal infections 118
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 118
Tryptophan Co-Metabolism at the Host-Pathogen Interface 117
CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models 116
Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis 116
Development and in vitro-in vivo performances of an inhalable indole-3-carboxaldehyde dry powder to target pulmonary inflammation and infection 115
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia 113
Tryptophan as a Central Hub for Host/Microbial Symbiosis 113
Biologics, Theranostics, and Personalized Medicine in Drug Delivery Systems 112
The IL-17F/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways 112
A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis 112
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis 108
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells 108
Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis 107
Leucine-rich repeat kinase 2 controls the Ca2+/nuclear factor of activated T Cells/IL-2 pathway during Aspergillus non-canonical autophagy in dendritic cells 106
Pulmonary drug delivery technology enables anakinra repurposing in cystic fibrosis 104
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 104
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease 99
The Mast Cell-Aryl Hydrocarbon Receptor Interplay at the Host-Microbe Interface 97
To Be or Not to Be a Pathogen: Candida albicans and Celiac Disease 97
Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems 95
Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk 94
Harnessing inter-kingdom metabolic disparities at the human-fungal interface for novel therapeutic approaches 92
Thymosin alpha 1 in cystic fibrosis: from the lung to the gut 90
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 89
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections 86
Thymosin β4 limits inflammation through autophagy 85
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 83
Griffonia simplicifolia seeds extract rich in 5-hydroxy-L-tryptophan reduces infection and inflammation in a mouse model of vulvovaginal candidiasis 82
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 80
Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation 80
Rapidly expanded partially HLA DRB1-matched fungus-specific T cells mediate in vitro and in vivo antifungal activity 78
Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines 77
Commensal fungi and oxalate degradation: is there a link? 77
The microbiota/host immune system interaction in the nose to protect from COVID-19 75
Small molecule ccr4 antagonists protect mice from aspergillus infection and allergy 75
Bacteria and fungi of the lung: allies or enemies? 72
The immune and microbial homeostasis determines the Candida–mast cells cross-talk in celiac disease 69
SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome 62
Unity Is Strength: The Mutual Alliance between CFTR and SLC26A6 as Therapeutic Opportunity in Cystic Fibrosis 58
Immune control of the basal ganglia network: Interleukin-17 as a key modulator of striatal synaptic plasticity 55
Host-microbe serotonin metabolism 45
Updates on Candida albicans infections: pathogenesis, resistance, and emerging nanopharmaceutical strategies 44
Innovative Approaches to Medical Rehabilitation: Regeneration, Immune Training, Homeostasis, and Microbiome Synergy 43
Enteric delivery of indole-3-carboxylic acid unlocks therapeutic potential of postbiotic metabolite cascade 41
Acetylcholine Sustains LNCaP Prostate Cancer Cell Migration, Invasion and Proliferation Through Glyoxalase 1/MG-H1 Axis with the Involvement of Osteopontin 39
PTEN/PKM2/ERα-Driven Glyoxalase 1 Overexpression Sustains PC3 Prostate Cancer Cell Growth Through MG-H1/RAGE Pathway Desensitization Leading to H2O2-Dependent KRIT1 Downregulation 38
The Gut Microbiome as a Possible Mediator in Autoimmunity and Cardiovascular Disease: Shared Pathways and Therapeutic Implications 26
Toward indole postbiotics precision therapy via AI-powered drug delivery technologies 26
Towards modeling enteric hyperoxaluria in a tripartite microbiota-gut-kidney microphysiological system 25
Totale 7.901
Categoria #
all - tutte 34.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022319 0 0 0 0 25 8 17 92 13 24 76 64
2022/2023909 48 170 13 69 109 88 7 46 319 4 30 6
2023/2024489 28 57 18 16 26 4 118 7 37 16 79 83
2024/20251.483 22 89 31 101 138 91 171 196 249 72 193 130
2025/20263.051 206 155 138 364 500 259 513 178 300 262 122 54
2026/20271.139 69 119 253 576 122 0 0 0 0 0 0 0
Totale 7.901